22 April, 2024Sofinnova Partners appoints two new partners, strengthening team of next generation investors
10 April, 2024Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
18 March, 2024Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
14 March, 2024Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy